Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hillman, A.L. Idarubicin More Cost-Effective than Daunorubicin?. Pharmacoeconomics 1, 68–69 (1992). https://doi.org/10.2165/00019053-199201010-00011
Published:
Issue Date:
DOI: https://doi.org/10.2165/00019053-199201010-00011